They found that GLE downregulates ERα expression, inhibits estrogen-inducible ER transactivation and inhibits tumor necrosis factor-alpha (TNFα)-stimulated activation of NF-κB in MCF-7 BC cells. The gene discussed is NFKB1; the disease is breast cancer.